Embolotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Embolotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : August, 2020 | Medical Devices | PPT format

Report Digest


Global Embolotherapy Market: Overview

Laudable advancements in the field of oncology have given a mark of credibility to the medical research fraternity. The global embolotherapy market is expected to grow at a sound pace in the years to follow. The presence of a handsome industry for looking into the development, prevention, and treatment of tumours in the human body is a key consideration for the healthcare industry. Furthermore, doctors and medical practitioners have, time and again, focused on the need to better devices, techniques, and equipment for blocking tumours and clot. Therefore, the global embolotherapy market is expected to attract handsome opportunities in the years to follow.

The abundant availability of materials such as gelatine powder, stainless steel, ethanol, and polyvinyl foam has played an integral role in the growth of the global market. The cost of procurement for these materials has influenced demand within the global embolotherapy market. Furthermore, sophistication of the medical industry with technical skill and clinical applications has also given a thrust to market growth.

There is little scope for doubt with regard to the emergence of a workable domain for embolotherapy. The selection of an embolic agent plays a key role in the success of embolization procedures which in turn enhances the prospects of market growth. Furthermore, the growing awareness of the masses about artery blockages has given a thrust to the growth of the global embolotherapy market.

A review on the embolotherapy market gives valued insights about the forces of supply and demand. The global embolotherapy market may be segmented on the basis of the following parameters: product, disease, procedure, and end-user. Based on end-user, the global embolotherapy market has attracted a substantial consumer base from clinics and hospitals.

Global Embolotherapy Market: Notable Developments

Advancements in the medical fraternity have reeked of growth across the global embolotherapy market. Some of the notable development that have ensued in this market are:

  • Several huge companies have resorted to the practice of buying majority shares in smaller companies. This move could help the former in exercising their control over unexplored regional markets. Boston Scientific Corporation acquired CeloNova BioSciences’ interventional radiology platform to expand its reigns in the domain of radiology.
  • Several companies with a decent portfolio in cancer research and treatment have also come forward to induct new strategies for growth. It is expected that the marketing and promotion campaigns of these companies would benefit the overall market.

Some of the notable players in the embolotherapy market are:

  • Abbott Laboratories (US)
  • BTG plc (UK)
  • Cook Medical (US)
  • Penumbra, Inc. (US)

Global Embolotherapy Market: Growth Drivers

  • Innovation to Lead Market Dynamics

As medical research institutes embrace innovation and forward-thinking, the domain of embolotherapy shall gain swing. The high incidence of diseases such as cancer and brain tumour has led to increased investments in the field of embolotherapy. Furthermore, new research practices have also made way for growth within the global embolotherapy market.

  • Availability of Improved Catheters

The use of catheters and balloons in embolization has emerged as a key consideration from the perspective of market growth. The need for better catheters is now met by availability of high-quality devices. Hence, the global embolotherapy market should expand alongside advancements in the field of medical device development. The need to prevent haemorrhaging and artery blocks has also generated commendable opportunities within the global embolotherapy market.

The global embolotherapy market is segmented as:

Product

  • Embolic agents
  • Microspheres
  • Embolic coils
    • Detachable Coils
    • Pushable Coils
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Detachable Balloons
  • Support Devices
  • Microcatheters
  • Guidewires

Disease Indication

  • Cancer
  • Liver Cancer
  • Kidney Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Neurological Diseases
  • Cerebral Aneurysm
  • Cerebral Arteriovenous Malformations and Fistulas
  • Gastrointestinal Disorders
  • Urological and Nephrological Disorders

Procedure

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.